Replicel Life Sciences Inc (RP.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 88 | 88 | 88 | 63 | 63 |
| Operating Expenses | 568 | 332 | 609 | 339 | 397 |
| Operating Income | -480 | -243 | -521 | -275 | -334 |
| Other Income | -875 | -11 | -77 | -54 | -27 |
| Pre-tax Income | -1,355 | -254 | -598 | -329 | -361 |
| Net Income Continuous | -1,355 | -254 | -598 | -329 | -361 |
| Net Income | $-1,355 | $-254 | $-598 | $-329 | $-361 |
| EPS Basic Total Ops | -0.04 | -0.01 | -0.02 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.04 | -0.01 | -0.02 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.04 | -0.01 | -0.02 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.04 | -0.01 | -0.02 | -0.01 | -0.01 |
| EBITDA(a) | $-479 | $-243 | $-521 | $-275 | $-333 |